Call MEDISCA now at 1-800-932-10391300 786 392


Non-Sterile Training

Target Audience

Pharmacists, pharmacy technicians, and other compounding personnel – whether new to non-sterile compounding, in need of a refresher, or looking to train you compounding team – this is the program for you!


Home Study (24 hours) & Learning Assessment (must obtain >75%) that reviews fundamental principles of non-sterile compounding in preparation for the live events.

Live Virtual Seminar (2 days x 6 hours) that allows you to connect and interact online, in real time, through open mic Q&A sessions, group discussions, polls, and online chats.

Lab Training (2 days x 6 hours) where you will received hands-on experience compounding 8 common non-sterile dosage forms in our laboratory facility located in Sydney, Australia.

*All three components (Home Study with Learning Assessment, Live Virtual Seminar, and Lab Training) are required for successful completion of the activity. Please note that the Live Virtual Seminar and Lab Training occur on different dates. Dates occurring in the same month are paired together (e.g., 19-20 Feb 2021 Virtual Seminar pairs with 27-28 Feb 2021 Lab Training). If any questions, please contact your MEDISCA Account Representative for more details.


This Practice-based Activity will provide compounding pharmacists and technicians with the competency to prepare current and viable pharmacotherapeutic non-sterile dosage forms. Unique concepts will be taught facilitating a decision-making process the pharmacist and technician can apply in their day-to-day practice.

Consideration will be given to meeting the physician’s prescription and patient-specific need, compliance-related solutions, medical necessity, and legal and regulatory guidelines. A significant emphasis will be placed on quality assurance and quality control as it relates to dosage form design, pharmaceutical calculations and the validation of preparatory procedures that are part of Master Formulation Records.

Practical techniques and technology-related applications are developed through hands-on experience in a compounding laboratory environment where pharmacists and technicians will be trained in all aspects of non-sterile preparatory procedures. Pharmacists and technicians have the opportunity to develop important aspects of a business development and marketing plan.

Learning Objectives

Home Study – Pharmacists*

  1. Relate unique and essential central core concepts
  2. Describe regulatory framework requirements
  3. Discuss standards of practice for non-hazardous and hazardous drug compounding
  4. Explain components of a standard operating procedure
  5. Apply business, marketing, and sales for a successful practice
  6. Explain characteristics for routes of delivery in non-sterile compounding
  7. Describe the chemical composition of different dosage forms
  8. Identify laboratory practices, procedures and preparatory techniques related to the compounding of non-sterile dosage forms
  9. Relate excipients to dosage forms, chemical composition, and routes of delivery
  10. 1Relate base types to dosage forms, chemical composition, and routes of delivery
  11. Illustrate the importance of drug monographs and certificates of analysis to compounding
  12. Describe techniques and technology used during compounding
  13. Apply the components of process development
  14. Describe the components of a master formulation record
  15. Discuss the requirements of a compounding record

Virtual Seminar & Lab Training – Pharmacists*

  1. Explain compounding as a viable therapeutic option
  2. Express unique marketing messages in support of a compounding practice
  3. Demonstrate the ability to manage expenses and revenues using a financial spreadsheet
  4. Assess acquisition costs in order to establish selling prices related to a compounding practice
  5. Write a standard operating procedure
  6. Apply regulations and standards to a non-hazardous and hazardous drug compounding practice
  7. Develop preparatory procedures for solutions and dispersions; suspensions and emulsions
  8. Solve pharmaceutical calculations used in pharmacy compounding
  9. Relate process development to the establishment of a master formulation record
  10. Prepare a master formulation record
  11. Design a non-sterile compounding facility in compliance with standards of practice
  12. Prepare a series of non-sterile compounded preparations
  13. Apply qualitative and quantitative assessments to compounded preparations

*For Technicians, please refer to the workbook for Learning Objectives.


Tammy Nguyen, BPharm, MPS

Compounding Pharmacist, MEDISCA Australia

Valentina Karan, BPharm

Product Development Management, The Compounding Pharmacy Australia

Patricia Ullmann, BPharm

Training & Technical Services Manager , MEDISCA Australia

Branko Radojkovic, BPharm, MClinPharm FSHP

Pharmacist, Royal Prince Edward Hospital

Rebecca O’Grady, BPharm, MPS GradCertPharmPrac

Technical Support Services Pharmacist, MEDISCA Australia

Claire Targett, BPharm

Pharmacist, Capital Chemist Charnwood

Aylin Ektem, BPharm

Compounding Pharmacist, Locum

*Facilitators are subject to change and event-specific.


The Home Study, Live Virtual Seminar, and Laboratory Training, together make up the CPD event and have been accredited for 48 hours of Group-2 CPD (or 96 CPD credits), suitable for inclusion in an individual pharmacists CPD plan.

APC Accredited CPD


Completion Requirements

Home Study: Complete home study learning assessment* prior to the live event.

Live Virtual Seminar: Attend in full and complete activity evaluation

Lab Training: Attend in full, complete practical skill set competency assessment*, and activity evaluation

*A maximum number of two attempts to achieve a 75% passing grade is required for all learning assessments and competency assessments.


Activity material is Copyright© LP3 Network Inc. 2003-2021.

Declarations and Disclosures

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network assist with the marketing of this activity. LP3 Network is an independent corporation. LP3 Network has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network as it relates to activity offerings.

Financial Support

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.

Cancellation and Refund Policy

In the event that MEDISCA Australia cancels a course, MEDISCA Australia’s sole liability shall be course repayment. In no event shall MEDISCA Australia be responsible for any costs arising from such cancellation, including but not limited to travel and/or accommodation. In the event a Registrant cancels their enrollment in a CPD Activity, a written request must be sent to MEDISCA Australia requesting ‘Cancellation without Transfer’ to an alternate live CPD Activity event date. If cancellation occurs at greater than or equal to 31 days from live activity event date, then registrant will receive a 75% refund; 15-30 days a 50% refund; and less than or equal to 14 days no refund. MEDISCA Australia shall be excused from any delay caused by reason of any occurrence or contingency beyond its reasonable control (a “Force Majeure”), including but not limited to, acts of God, hurricane, earthquake, labour disputes, strikes, riots, war, and governmental requirements. The obligation to pay money to MEDISCA Australia in a timely manner is absolute and shall not be subject to this Force Majeure provision. In such event, MEDISCA Australia will not issue any refunds, only transfer to an alternate live activity event date. This cancellation and refund policy is specific to courses offered in Australia. To obtain information on the cancellation and refund policy for courses offered outside of Australia, please speak to a MEDISCA Australia representative or refer to your course-specific registration page.

Transfer Policy – Australia Courses Only

This transfer policy is only applicable to courses that are offered in Australia. Transfer policy is only in effect if requested greater than or equal to 14 days prior to the original live activity event date. Failure to submit “Transfer Request” at least 14 days prior to original live activity event date will default to “Cancellation and Refund Policy”. Transfer policy can only apply one (1) time. Transfer to a new live event date must be within current calendar year. Failure to attend the new live activity event will lead to no refund and will no longer be transferable. Confirmation of new activity date is subject to the approval by MEDISCA Australia based on the number of available seats within the selected live activity event.


We have placed cookies on your device to help make this website better.

We also use cookies to collect information for making reports and to help us improve the site. The cookies collect information in an anonymous form.

Copyright® 1989-2021 Medisca Inc.
All rights reserved

MEDISCA is ISO 9001:2008 certified